Vermeer-de Bondt PE - Search Results

1

[Prevalence of undescended testis in the first 4 years of life; a longitudinal study].

van Gelderen HH, Vermeer-de Bondt PE. van Gelderen HH, et al. Ned Tijdschr Geneeskd. 1986 Aug 30;130(35):1567-70. Ned Tijdschr Geneeskd. 1986. PMID: 2876394 Dutch. No abstract available.

2

[Possible exposure to rabies in anamnesis: rabies advice in the Netherlands].

Beaujean DJ, van Ouwerkerk IM, Timen A, Burgmeijer RJ, Vermeer de Bondt PE, van Steenbergen JE. Beaujean DJ, et al. Among authors: vermeer de bondt pe. Ned Tijdschr Geneeskd. 2008 Mar 1;152(9):473-7. Ned Tijdschr Geneeskd. 2008. PMID: 18389875 Dutch.

3

[Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers].

van der Ploeg CP, Kateman H, Vermeer-de Bondt PE, Verkerk PH. van der Ploeg CP, et al. Ned Tijdschr Geneeskd. 2004 Sep 11;148(37):1820-4. Ned Tijdschr Geneeskd. 2004. PMID: 15495511 Dutch.

4

[Protection of children born to hepatitis-B-infected mothers].

Boot HJ, Vermeer-de Bondt PE, Kimman TG. Boot HJ, et al. Ned Tijdschr Geneeskd. 2004 Sep 11;148(37):1816-8. Ned Tijdschr Geneeskd. 2004. PMID: 15495509 Review. Dutch.

5

[Increase in the number of invasive Haemophilus influenzae type b infections].

Spanjaard L, van den Hof S, de Melker HE, Vermeer-de Bondt PE, van der Ende A, Rijkers GT. Spanjaard L, et al. Ned Tijdschr Geneeskd. 2005 Dec 3;149(49):2738-42. Ned Tijdschr Geneeskd. 2005. PMID: 16375019 Dutch.

6

[Fetal hydrops and parvovirus B19 infection].

Vermeer-de Bondt PE, Twaalfhoven FC, Kragt H. Vermeer-de Bondt PE, et al. Ned Tijdschr Geneeskd. 1990 Feb 3;134(5):218-21. Ned Tijdschr Geneeskd. 1990. PMID: 2154708 Review. Dutch. No abstract available.

7

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011.

Schoffelen T, Wong A, Rümke HC, Netea MG, Timen A, van Deuren M, Vermeer-de Bondt PE. Schoffelen T, et al. Among authors: vermeer de bondt pe. Vaccine. 2014 Nov 20;32(49):6622-30. doi: 10.1016/j.vaccine.2014.09.061. Vaccine. 2014. PMID: 25446824

8

Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever.

Vermeer-de Bondt PE, Schoffelen T, Vanrolleghem AM, Isken LD, van Deuren M, Sturkenboom MC, Timen A. Vermeer-de Bondt PE, et al. PLoS One. 2015 Apr 24;10(4):e0123570. doi: 10.1371/journal.pone.0123570. eCollection 2015. PLoS One. 2015. PMID: 25909712 Free PMC article.

9

[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].

van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE. van der Maas NA, et al. Ned Tijdschr Geneeskd. 2007 Dec 8;151(49):2732-7. Ned Tijdschr Geneeskd. 2007. PMID: 18225797 Dutch.

10

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.

Kimman TG, Boot HJ, Berbers GA, Vermeer-de Bondt PE, Ardine de Wit G, de Melker HE. Kimman TG, et al. Vaccine. 2006 May 29;24(22):4769-78. doi: 10.1016/j.vaccine.2006.03.022. Epub 2006 Mar 27. Vaccine. 2006. PMID: 16616803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters